4.4 Article

Changes in Na+ channel expression and nodal persistent Na+ currents associated with peripheral nerve regeneration in mice

Journal

MUSCLE & NERVE
Volume 37, Issue 6, Pages 721-730

Publisher

JOHN WILEY & SONS INC
DOI: 10.1002/mus.21031

Keywords

excitability; K+ channel; Na+ channel; peripheral nerve; persistent Na+ channel; regeneration; Wallerian degeneration

Ask authors/readers for more resources

Patients with peripheral neuropathy frequently suffer from positive sensory (pain and paresthesias) and motor (muscle cramping) symptoms even in the recovery phase of the disease. To investigate the pathophysiology of increased axonal excitability in peripheral nerve regeneration, we assessed the temporal and spatial expression of voltage-gated Na+ channels as well as nodal persistent Na+ currents in a mouse model of Wallerian degeneration. Crushed sciatic nerves of 8-week-old C57/BL6J male mice underwent complete Wallerian degeneration at 1 week. Two weeks after crush, there was a prominent increase in the number of Na+ channel clusters per unit area, and binary or broad Na+ channel clusters were frequently found. Excess Na+ channel clusters were retained up to 20 weeks post-injury. Excitability testing using latent addition suggested that nodal persistent Na+ currents markedly increased beginning at week 3, and remained through week 10. These results suggest that axonal regeneration is associated with persistently increased axonal excitability resulting from increases in the number and conductance of Na+ channels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder

A. Uzawa, M. Mori, H. Masuda, R. Ohtani, T. Uchida, R. Aoki, S. Kuwabara

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Article Immunology

Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study

A. Uzawa, Y. Kojima, Y. Ozawa, M. Yasuda, Y. Onishi, H. Akamine, N. Kawaguchi, K. Himuro, S. Kuwabara

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Article Geriatrics & Gerontology

Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis

Ryoichi Nakamura, Genki Tohnai, Naoki Atsuta, Masahiro Nakatochi, Naoki Hayashi, Hazuki Watanabe, Daichi Yokoi, Hirohisa Watanabe, Masahisa Katsuno, Yuishin Izumi, Akira Taniguchi, Kazuaki Kanai, Mitsuya Morita, Osamu Kano, Satoshi Kuwabara, Masaya Oda, Koji Abe, Masashi Aoki, Ikuko Aiba, Koichi Okamoto, Kouichi Mizoguchi, Nobutaka Hattori, Kenji Nakashima, Ryuji Kaji, Gen Sobue

Summary: Two recent genetic studies found that loss-of-function mutation of the C-terminal cargo-binding tail domain of the KIF5A gene cause amyotrophic lateral sclerosis (ALS). This study in Japanese patients with sporadic ALS identified a novel loss-of-function variant in KIF5A, highlighting its rare occurrence as a cause of ALS.

NEUROBIOLOGY OF AGING (2021)

Editorial Material Clinical Neurology

'Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs' by Marsh et al

Satoshi Kuwabara, Tomoki Suichi, Sonoko Misawa

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Editorial Material Clinical Neurology

Different patterns of brainstem and cerebellar MRI abnormalities in demyelinating disorders with MOG and aquaporin-4 antibodies

Akiyuki Uzawa, Masahiro Mori, Satoshi Kuwabara

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Review Clinical Neurology

Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review

Felix Kohle, Satoshi Kuwabara, Helmar Christoph Lehmann

Summary: Pregnancy can trigger typical CIDP in some women, and women with CIDP have a higher risk of relapse during pregnancy. The onset or relapse of CIDP during pregnancy is a rare but challenging constellation for physicians.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Clinical Neurology

Novel serum autoantibodies against ss-actin (ACTB) in amyotrophic lateral sclerosis

Kazuo Sugimoto, Masahiro Mori, Jia Liu, Kazutomo Shibuya, Sagiri Isose, Mizuho Koide, Takaki Hiwasa, Satoshi Kuwabara

Summary: Novel biomarkers were identified in ALS patients using the SEREX method, with beta-actin (ACTB) showing significantly higher serum levels in ALS patients compared to normal controls and Parkinson disease patients. Anti-ACTB antibody levels were associated with disease severity and progression in ALS patients, suggesting their potential as a biomarker for ALS.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2021)

Article Clinical Neurology

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

Hiroki Masuda, Masahiro Mori, Shigeki Hirano, Akiyuki Uzawa, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Reiji Aoki, Satoshi Kuwabara

Summary: The research found that patients with NMOSD were older and had a higher disability status score at baseline MRI compared to those with MS. There were no significant differences in disease duration, annual relapse rate, and intervals from the last attack and from disease-modifying drugs initiation between the two groups.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Intravenous immunoglobulin treatment for mild Guillain-Barre syndrome: an international observational study

Christine Verboon, Thomas Harbo, David R. Cornblath, Richard A. C. Hughes, Pieter A. van Doorn, Michael P. Lunn, Kenneth C. Gorson, Fabio Barroso, Satoshi Kuwabara, Giuliana Galassi, Helmar C. Lehmann, Susumu Kusunoki, Ricardo C. Reisin, Davide Binda, Guido Cavaletti, Bart C. Jacobs

Summary: In patients with mild GBS, treatment with one course of IVIg did not improve the disease course overall. Despite some benefits such as shorter time to regain muscle strength, residual symptoms were often present after one year, indicating the need for better treatments for mild GBS.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Editorial Material Clinical Neurology

Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis

Hiroki Masuda, Masahiro Mori, Satoshi Kuwabara

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Immunology

Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis

Manato Yasuda, Akiyuki Uzawa, Yukiko Ozawa, Yuta Kojima, Yosuke Onishi, Hiroyuki Akamine, Satoshi Kuwabara

Summary: A retrospective study comparing IA and IVIg treatment in 19 AChR antibody-positive generalized MG patients showed that IA was safer and more effective in improving MG-ADL scores compared to IVIg. More large prospective studies are needed to confirm these findings.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Editorial Material Clinical Neurology

Microstructural changes in the normal appearance cerebral cortex of multiple sclerosis detected by an advanced diffusion MRI technique

Atsuhiko Sugiyama, Satoshi Kuwabara

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Editorial Material Clinical Neurology

Validation of the 2021 EAN/PNS diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

Satoshi Kuwabara, Tomoki Suichi

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori P. Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa

Summary: Early fast-acting treatment (EFT), including plasmapheresis, intravenous immunoglobulin and/or intravenous high-dose methylprednisolone (IVMP), is beneficial for achieving minimal manifestations (MM) or <= 5 mg/day prednisolone (MM5mg) in patients with myasthenia gravis (MG). This study aimed to identify the effective EFT regimen and patient characteristics. The results showed that EFT was effective for all types of MG, and the inclusion of IVMP and early use of calcineurin inhibitors promoted the achievement of MM5mg.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan

Hiroaki Yoshikawa, Yumi Adachi, Yosikazu Nakamura, Nagato Kuriyama, Hiroyuki Murai, Yoshiko Nomura, Yasunari Sakai, Kazuo Iwasa, Yutaka Furukawa, Satoshi Kuwabara, Makoto Matsui

Summary: This study is the first nationwide epidemiological survey of Lambert-Eaton myasthenic syndrome (LEMS) in Japan. The results show that the prevalence of LEMS in Japan is similar to that in other countries. A significant proportion of LEMS patients have associated tumors, with a predominance of men in tumor-associated LEMS (paraneoplastic LEMS, P-LEMS), and women in LEMS without tumors (a primary autoimmune form of LEMS, AI-LEMS).

BMJ NEUROLOGY OPEN (2022)

No Data Available